Sort
85,873 grants matching “alzheimers”
GMP Production and Extended Toxicology of an Oral Formulation Drug for Alzheimer's Disease
$1,370,663D. Martin Watterson · Northwestern University At Chicago · U01 · FY2024 · AG
Inherited Disease, Caregiving, and Social Networks
$1,370,528Laura M Koehly · National Human Genome Research Institute · ZIA · FY2022 · HG
NEURONAL &VASCULAR PATHOBIOLOGY IN ALZHEIMER'S DISEASE
$1,370,407Nathan S. Kline Institute For Psych Res · P01 · FY2000 · AG
Molecular Chaperones and DNA Replication
$1,370,054Sue H Wickner · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Structural basis for ApoE4-induced Alzheimer's disease
$1,370,000Gregory Bowman · University Of Pennsylvania · RF1 · FY2021 · AG
Clinical and Pathological Studies in the Oldest Old
$1,369,210Claudia H. Kawas · University Of California-Irvine · R01 · FY2012 · AG
Intelligent Systems for Detection of Aging Changes
$1,369,116Jeffrey A Kaye · Oregon Health & Science University · R01 · FY2008 · AG
Arizona Alzheimer's Disease Core Center
$1,368,983Eric M Reiman · Banner Sun Health Research Institute · P30 · FY2007 · AG
NexGen 7T MRI scanner for mesoscale brain imaging: Integration and Dissemination
$1,368,856David Alan Feinberg · University Of California Berkeley · U24 · FY2025 · NS
Droplet-based Spatially Encoded Live Cell Digital Extraction
$1,368,750Jina Ko · University Of Pennsylvania · DP2 · FY2023 · GM
Signaling Transduction and Alzheimer's Disease
$1,368,719Paul Greengard · Rockefeller University · P01 · FY2008 · AG
National Cell Repository for Alzheimer's Disease (NCRAD)
$1,368,628Tatiana M. Foroud · Indiana University Indianapolis · U24 · FY2017 · AG
AMYLOID PLAQUE AND TANGLE IMAGING IN AGING AND DEMENTIA
$1,368,366Gary William Small · University Of California Los Angeles · P01 · FY2007 · AG
How do parvalbumin interneuron-generated gamma oscillations organize prefrontal networks to promote behavioral adaptation?
$1,368,220Vikaas Singh Sohal · University Of California, San Francisco · R01 · FY2020 · NS
Analytical Validation of Non-native Transthyretin (NNTTR) As A Candidate Biomarker for Transthyretin Amyloidoses (ATTR)
$1,368,143Xin Jiang · Protego Biopharma, Inc. · U44 · FY2021 · NS
A 26-week rat toxicity study and efficacy and biomarker studies in Tau-APP Alzheimer's mouse model to support a Phase 1b clinical study
$1,367,955James G. Moe · Oligomerix, Inc · R44 · FY2023 · AG
Identifying resilience proteins in key motor tissues that drive motor and cognitive decline and offset the negative effects of ADRD pathologies within and outside the brain
$1,367,799Aron S Buchman · Rush University Medical Center · R01 · FY2025 · AG
Leveraging Longitudinal Data and Informatics Technology to Understand the Role of Bilingualism in Cognitive Resilience, Aging and Dementia
$1,367,793Li Zhou · Brigham And Women'S Hospital · R01 · FY2024 · AG
Dynamic Inverse Solutions for Multimodal Imaging
$1,367,617David A Boas · Massachusetts General Hospital · R01 · FY2010 · EB
Preclinical Alzheimer Disease and Driving
$1,367,256Catherine M Roe · Washington University · R01 · FY2019 · AG
Mild Cognitive Impairment: A Prospective Community Study
$1,366,981Mary Ganguli · University Of Pittsburgh At Pittsburgh · R01 · FY2013 · AG
BRAIN CONNECTS: Mapping Connectivity of the Human Brainstem in a Nuclear Coordinate System
$1,366,957Bruce Fischl · Massachusetts General Hospital · U01 · FY2024 · NS
Alzheimer's Disease Core Center
$1,366,818John Q. Trojanowski · University Of Pennsylvania · P30 · FY2009 · AG
The LUCINDA Trial
$1,366,388Tracy A. Butler · Weill Medical Coll Of Cornell Univ · R01 · FY2022 · AG
CORE--CLINICAL
$1,366,288Leon J Thal · University Of California, San Diego · P50 · FY2008 · AG